The Patent Finder

Viropharma Incorporated

1 patent currently held · Updated Nov 21, 2026
16 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 2 name spellings.

Recorded as renamed to Shire Viropharma LLC (2015)

0
Ending by 2030
Sep 2031
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

No maintenance fee falls due on this company's record before Nov 21, 2027.

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 1 of 1

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,737,168Compounds, Compositions, and Methods for Treatment and Prevention of Orthopoxvirus Infections and Associated Diseases
In force
 · High confidence
In forceHigh confidence
Also on record, not counted in the 1: 16 patents in force now held by others · 13 lapsed for an unpaid fee · 12 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

3 abandoned · 5 no status recorded

Showing 1 to 8 of 8, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.

ApplicationTitleFiledStatus
14/511,314Methods of Inhibiting the Alternative Pathway of Complement Immune System Activation and Compositions Used ThereinOct 10, 2014Abandoned
13/875,489Crystalline Phases of 5,6-Dichloro-2-(ISOPROPYLAMINO)-(1-ß-L-RIBOFURANOSYL)-1H-BENZIMIDAZOLEMay 2, 2013Abandoned
13/821,801Sep 7, 2011No status recorded
12/493,736Jun 29, 2009No status recorded
12/168,645Jul 7, 2008No status recorded
11/704,505Novel HCV inhibitor combinations and methodsFeb 9, 2007Abandoned
11/558,382Nov 9, 2006No status recorded
10/567,649Aug 13, 2004No status recorded
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited